Literature DB >> 12153801

Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration.

Paulo E Stanga1, Andres Kychenthal, Frederick W Fitzke, Anthony S Halfyard, Roger Chan, Alan C Bird, George W Aylward.   

Abstract

PURPOSE: To test the feasibility of a new surgical technique and to assess visual function over the translocated retinal pigment epithelium (RPE) cells in patients operated on for subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (ARMD).
DESIGN: Retrospective, noncomparative, interventional case series. PARTICIPANTS: Nine patients with previously untreated exudative ARMD underwent surgical excision of the subfoveal CNV with RPE translocation and were observed for 12 to 32 months.
METHODS: The surgery consisted of a standard three-port pars plana vitrectomy, excision of the CNV, and RPE translocation. Pre- and postoperative ocular examination included best-corrected visual acuity measurement, fundus color stereo photography, and fundus fluorescein angiography. Optical coherence tomography and confocal laser scanning ophthalmoscopy (cLSO) were performed after surgery. A crossfixation target and a single-point flashing light were projected on different areas of the posterior pole using a cLSO. Photopic 10 to 2 perimetry, photopic fine matrix mapping, and cLSO microperimetry were also performed after surgery in six patients. MAIN OUTCOME MEASURES: Optical coherence tomography cross-sectional scans and cLSO RPE autofluorescence were recorded to detect the presence of viable translocated RPE. Visual acuity, fixation, photopic 10 to 2 perimetry, photopic fine matrix mapping, and cLSO microperimetry were used to test central visual function.
RESULTS: Retinal pigment epithelium was translocated successfully at the time of CNV removal from the edge of the RPE defect to a subfoveal location in seven of nine patients. One patient experienced proliferative vitreoretinopathy, but significant hemorrhage was not a feature. Optical coherence tomography showed the translocated RPE as an area of increased optical reflectivity with optical shadowing external to it. Confocal laser scanning ophthalmoscopy showed autofluorescence of the translocated RPE. The crossfixation target was seen when projected on the translocated RPE. During eccentric fixation, the patients could see a flashing point-target projected on the translocated RPE. Photopic 10 to 2 perimetry, photopic fine-matrix mapping, and cLSO microperimetry showed the presence of central visual function.
CONCLUSIONS: The authors propose that translocation of RPE at the time of CNV removal, from the edge of the RPE defect to a subfoveal location, may have a role in the surgical management of ARMD.

Entities:  

Mesh:

Year:  2002        PMID: 12153801     DOI: 10.1016/s0161-6420(02)01099-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

1.  Comparison of the growth potential of retinal pigment epithelial cells obtained during vitrectomy in patients with age-related macular degeneration or complex retinal detachment.

Authors:  Jan C van Meurs; Ellen ter Averst; Rebecca Croxen; Leo Hofland; P Martin van Hagen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-22       Impact factor: 3.117

2.  Choroidal translocation with a pedicle following excision of a type 1 choroidal neovascular membrane.

Authors:  R I Angunawela; T H Williamson; M A J Khan; V Chong
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 3.  Stem cell therapies for retinal diseases: recapitulating development to replace degenerated cells.

Authors:  Cuiping Zhao; Qingjie Wang; Sally Temple
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

4.  [Autologous RPE-choroid translocation in exudative AMD. A case series of 10 consecutive patients].

Authors:  F Treumer; C Klatt; J Roider
Journal:  Ophthalmologe       Date:  2007-09       Impact factor: 1.059

5.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

6.  Deep Scleral Exposure: A Degenerative Outcome of End-Stage Stargardt Disease.

Authors:  Winston Lee; Jana Zernant; Takayuki Nagasaki; Stephen H Tsang; Rando Allikmets
Journal:  Am J Ophthalmol       Date:  2018-07-26       Impact factor: 5.258

7.  Histological evidence for revascularisation of an autologous retinal pigment epithelium--choroid graft in the pig.

Authors:  Kristel J M Maaijwee; Jan C van Meurs; Bernd Kirchhof; Cornelia M Mooij; Jurgen H Fischer; Jerzy Mackiewicz; Karin Kobuch; Antonia M Joussen
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

8.  COMBINED AUTOLOGOUS TRANSPLANTATION OF NEUROSENSORY RETINA, RETINAL PIGMENT EPITHELIUM, AND CHOROID FREE GRAFTS.

Authors:  Barbara Parolini; Dilraj S Grewal; Sajish J Pinackatt; Andrea Baldi; Attilio Di Salvatore; Gianluca Besozzi; Alessandro Finzi; Daniele Cardillo; Tamer H Mahmoud
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

9.  Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.

Authors:  Lyndon da Cruz; Kate Fynes; Odysseas Georgiadis; Julie Kerby; Yvonne H Luo; Ahmad Ahmado; Amanda Vernon; Julie T Daniels; Britta Nommiste; Shazeen M Hasan; Sakina B Gooljar; Amanda-Jayne F Carr; Anthony Vugler; Conor M Ramsden; Magda Bictash; Mike Fenster; Juliette Steer; Tricia Harbinson; Anna Wilbrey; Adnan Tufail; Gang Feng; Mark Whitlock; Anthony G Robson; Graham E Holder; Mandeep S Sagoo; Peter T Loudon; Paul Whiting; Peter J Coffey
Journal:  Nat Biotechnol       Date:  2018-03-19       Impact factor: 54.908

10.  [Transplantation of retinal pigment pithelium (RPE) following CNV removal in patients with AMD. Techniques, results, outlook].

Authors:  A Bindewald; F Roth; J Van Meurs; F G Holz
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.